Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. more
Time Frame | LQDA | Sector | S&P500 |
---|---|---|---|
1-Week Return | -4.68% | -2.12% | 0.77% |
1-Month Return | 3.48% | -2.54% | 2.65% |
3-Month Return | 21.06% | -6.28% | 12.3% |
6-Month Return | -20.91% | -1.36% | 13.48% |
1-Year Return | 53.34% | 9.29% | 33.47% |
3-Year Return | 174.56% | 10.05% | 32.22% |
5-Year Return | 170.52% | 43.69% | 92.85% |
10-Year Return | -0.81% | 103.1% | 194.31% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 8.07M | 739.63K | 12.85M | 15.94M | 17.49M | [{"date":"2019-12-31","value":46.16,"profit":true},{"date":"2020-12-31","value":4.23,"profit":true},{"date":"2021-12-31","value":73.5,"profit":true},{"date":"2022-12-31","value":91.12,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 807.19K | 237.71K | 3.02M | 2.86M | 2.89M | [{"date":"2019-12-31","value":26.7,"profit":true},{"date":"2020-12-31","value":7.86,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.58,"profit":true},{"date":"2023-12-31","value":95.54,"profit":true}] |
Gross Profit | 7.26M | 501.92K | 9.83M | 13.08M | 14.60M | [{"date":"2019-12-31","value":49.76,"profit":true},{"date":"2020-12-31","value":3.44,"profit":true},{"date":"2021-12-31","value":67.33,"profit":true},{"date":"2022-12-31","value":89.56,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 90.00% | 67.86% | 76.48% | 82.06% | 83.49% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":75.4,"profit":true},{"date":"2021-12-31","value":84.98,"profit":true},{"date":"2022-12-31","value":91.18,"profit":true},{"date":"2023-12-31","value":92.76,"profit":true}] |
Operating Expenses | 54.09M | 59.59M | 43.63M | 51.85M | 87.98M | [{"date":"2019-12-31","value":61.48,"profit":true},{"date":"2020-12-31","value":67.73,"profit":true},{"date":"2021-12-31","value":49.59,"profit":true},{"date":"2022-12-31","value":58.93,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (46.82M) | (59.09M) | (33.80M) | (38.77M) | (73.38M) | [{"date":"2019-12-31","value":-4682354900,"profit":false},{"date":"2020-12-31","value":-5908913000,"profit":false},{"date":"2021-12-31","value":-3379704300,"profit":false},{"date":"2022-12-31","value":-3877000000,"profit":false},{"date":"2023-12-31","value":-7338400000,"profit":false}] |
Total Non-Operating Income/Expense | (1.52M) | (1.35M) | (1.56M) | (3.49M) | (6.95M) | [{"date":"2019-12-31","value":-151981200,"profit":false},{"date":"2020-12-31","value":-134727800,"profit":false},{"date":"2021-12-31","value":-156325300,"profit":false},{"date":"2022-12-31","value":-349300000,"profit":false},{"date":"2023-12-31","value":-694700000,"profit":false}] |
Pre-Tax Income | (47.58M) | (59.76M) | (34.58M) | (41.02M) | (78.50M) | [{"date":"2019-12-31","value":-4758345500,"profit":false},{"date":"2020-12-31","value":-5976276900,"profit":false},{"date":"2021-12-31","value":-3457864800,"profit":false},{"date":"2022-12-31","value":-4101500000,"profit":false},{"date":"2023-12-31","value":-7850200000,"profit":false}] |
Income Taxes | (1.19M) | (2.27M) | (4.80M) | (2.65M) | (2.18M) | [{"date":"2019-12-31","value":-119412000,"profit":false},{"date":"2020-12-31","value":-227158100,"profit":false},{"date":"2021-12-31","value":-479683900,"profit":false},{"date":"2022-12-31","value":-265000000,"profit":false},{"date":"2023-12-31","value":-217800000,"profit":false}] |
Income After Taxes | (46.39M) | (57.49M) | (29.78M) | (38.37M) | (76.32M) | [{"date":"2019-12-31","value":-4638933500,"profit":false},{"date":"2020-12-31","value":-5749118800,"profit":false},{"date":"2021-12-31","value":-2978180900,"profit":false},{"date":"2022-12-31","value":-3836500000,"profit":false},{"date":"2023-12-31","value":-7632400000,"profit":false}] |
Income From Continuous Operations | (47.58M) | (59.76M) | (34.58M) | (41.02M) | (57.59M) | [{"date":"2019-12-31","value":-4758345500,"profit":false},{"date":"2020-12-31","value":-5976276900,"profit":false},{"date":"2021-12-31","value":-3457864800,"profit":false},{"date":"2022-12-31","value":-4101500000,"profit":false},{"date":"2023-12-31","value":-5758500000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (46.39M) | (57.49M) | (29.78M) | (38.37M) | (78.50M) | [{"date":"2019-12-31","value":-4638933500,"profit":false},{"date":"2020-12-31","value":-5749118800,"profit":false},{"date":"2021-12-31","value":-2978180900,"profit":false},{"date":"2022-12-31","value":-3836500000,"profit":false},{"date":"2023-12-31","value":-7850200000,"profit":false}] |
EPS (Diluted) | (2.62) | (1.79) | (0.71) | (0.68) | (1.20) | [{"date":"2019-12-31","value":-262,"profit":false},{"date":"2020-12-31","value":-179,"profit":false},{"date":"2021-12-31","value":-71,"profit":false},{"date":"2022-12-31","value":-68,"profit":false},{"date":"2023-12-31","value":-120,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
LQDA | |
---|---|
Cash Ratio | 6.04 |
Current Ratio | 6.33 |
Quick Ratio | 6.33 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
LQDA | |
---|---|
ROA (LTM) | -40.69% |
ROE (LTM) | -181.73% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
LQDA | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.56 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.44 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
LQDA | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 62.79 |
P/B | 8.43 |
Price/FCF | NM |
EV/R | 46.78 |
EV/Ebitda | NM |
Liquidia Technologies Inc (LQDA) share price today is $11.01
Yes, Indians can buy shares of Liquidia Technologies Inc (LQDA) on Vested. To buy Liquidia Technologies Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LQDA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Liquidia Technologies Inc (LQDA) via the Vested app. You can start investing in Liquidia Technologies Inc (LQDA) with a minimum investment of $1.
You can invest in shares of Liquidia Technologies Inc (LQDA) via Vested in three simple steps:
The 52-week high price of Liquidia Technologies Inc (LQDA) is $16.99. The 52-week low price of Liquidia Technologies Inc (LQDA) is $6.86.
The price-to-earnings (P/E) ratio of Liquidia Technologies Inc (LQDA) is
The price-to-book (P/B) ratio of Liquidia Technologies Inc (LQDA) is 8.43
The dividend yield of Liquidia Technologies Inc (LQDA) is 0.00%
The market capitalization of Liquidia Technologies Inc (LQDA) is $971.63M
The stock symbol (or ticker) of Liquidia Technologies Inc is LQDA